• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Authors' reply.

作者信息

Chan W-K, Dan Y Y, Wong V W-S

机构信息

Faculty of Medicine, University of Malaya, Malaysia.

National University of Singapore, Singapore.

出版信息

Aliment Pharmacol Ther. 2018 Apr;47(7):1037-1038. doi: 10.1111/apt.14572.

DOI:10.1111/apt.14572
PMID:29512909
Abstract
摘要

相似文献

1
Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer. Authors' reply.社论：亚洲的非酒精性脂肪性肝病——与晚期疾病的临床关联日益明晰。作者回复。
Aliment Pharmacol Ther. 2018 Apr;47(7):1037-1038. doi: 10.1111/apt.14572.
2
Editorial: NAFLD in Asia-clinical associations with advanced disease become clearer.社论：亚洲的非酒精性脂肪性肝病——与晚期疾病的临床关联愈发清晰。
Aliment Pharmacol Ther. 2018 Apr;47(7):1035-1036. doi: 10.1111/apt.14557.
3
Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD - authors' reply.社论：使用先进磁共振成像技术监测非酒精性脂肪性肝病的更多证据——作者回复
Aliment Pharmacol Ther. 2017 May;45(9):1271-1272. doi: 10.1111/apt.14037.
4
Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.社论：重新审视非酒精性脂肪性肝病合并晚期纤维化时的心血管危险因素？作者回复。
Aliment Pharmacol Ther. 2020 May;51(10):988-989. doi: 10.1111/apt.15696.
5
Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? Authors' reply.社论：基于尿液的代谢组学能否改善非酒精性脂肪性肝病晚期纤维化的诊断？作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(11):1205-1206. doi: 10.1111/apt.15756.
6
Editorial: stepwise risk stratification for both F3 and F4 in NAFLD patients-authors' reply.编者按：非酒精性脂肪性肝病患者F3和F4的逐步风险分层——作者回复
Aliment Pharmacol Ther. 2018 Dec;48(11-12):1318-1319. doi: 10.1111/apt.15040.
7
Editorial: collagen proportionate area as a prognostic indicator in NAFLD-authors' reply.社论：胶原比例面积作为非酒精性脂肪性肝病的预后指标——作者回复
Aliment Pharmacol Ther. 2019 Jun;49(11):1454-1455. doi: 10.1111/apt.15271.
8
Editorial: NAFLD in HIV infection--call for action. Authors' reply.社论：HIV感染中的非酒精性脂肪性肝病——呼吁采取行动。作者回复。
Aliment Pharmacol Ther. 2015 Mar;41(6):591. doi: 10.1111/apt.13087.
9
An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia.亚洲非酒精性脂肪性肝病和非酒精性脂肪性肝炎的最新情况
Expert Rev Gastroenterol Hepatol. 2017 Aug;11(8):759-772. doi: 10.1080/17474124.2017.1342535. Epub 2017 Jun 20.
10
Editorial: clinical outcomes in lean NAFLD - the devil is in the details. Authors' reply.社论：非酒精性脂肪性肝病（NAFLD）的临床结局——细节决定成败。作者回复。
Aliment Pharmacol Ther. 2023 May;57(9):1042-1043. doi: 10.1111/apt.17453.